Sign In
Buy GSK
$50.67
-1.48 (-2.84%)
At Close: Jun 18, 2026
3 Millionaire-Maker Biotech Stocks to Buy Before the Window Closes
03:00pm, Sunday, 30'th Jul 2023
The pharmaceutical sector generates a huge $1.2 trillion of revenue globally, and the U.S. is by far the most lucrative country for drug makers in the world. Therefore, the profits of successful Ameri
Is GSK Stock Worth Buying Right Now?
07:30pm, Saturday, 29'th Jul 2023
British drugmaker GSK has been in reorganization mode since 2017. The new GSK should sport higher growth, profitability, and increased productivity.
GSK Beats on Q2 Earnings & Sales, Raises 2023 Guidance
12:25pm, Wednesday, 26'th Jul 2023
GSK's revenues benefit from strong growth across all segments, especially HIV and vaccine. GSK raises guidance for earnings and sales.
GSK chief says RSV vaccine will start off slower than shingles shot – but will drive future sales
12:11pm, Wednesday, 26'th Jul 2023
London-based GSK is preparing to roll out its RSV vaccine in the U.S. and European Union this fall, when the disease begins to spread at higher levels.
GSK (GSK) Surpasses Q2 Earnings and Revenue Estimates
08:40am, Wednesday, 26'th Jul 2023
GSK (GSK) came out with quarterly earnings of $0.97 per share, beating the Zacks Consensus Estimate of $0.85 per share. This compares to earnings of $0.87 per share a year ago.
India's GlaxoSmithKline Pharma posts rise in Q1 profit on steady vaccine business
08:21am, Wednesday, 26'th Jul 2023
GlaxoSmithKline Pharmaceuticals , the Indian unit of UK's GSK plc , posted an 11% rise in first-quarter profit on Wednesday, buoyed by strong demand for its vaccines.
GSK expects RSV vaccine uptake will be slower than for its shingles vaccine-CEO
05:32am, Wednesday, 26'th Jul 2023
GSK does not expect uptake of its RSV vaccine will initially be as swift as it was for its blockbuster shingles vaccine, though the company is confident in its new inoculation, Chief Executive Emma Wa
GSK upgrades forecasts as shingles vaccine continues to deliver
03:03am, Wednesday, 26'th Jul 2023
GSK PLC (LSE:GSK, NYSE:GSK) has upgraded its 2023 guidance following a strong second-quarter performance, driven by key growth drivers including its Shingrix vaccine for shingles. The pharmaceutical
Lloyds, GSK, Reckitt and BAT results lead a busy Wednesday, plus Fed meeting
08:59am, Tuesday, 25'th Jul 2023
Although Wednesday is Fed day, before that there's going to be a raft of news from big FTSE and Wall Street companies before the US central bank meets late in the day. Lloyds Banking Group PLC (LSE:L
GSK or TECH: Which Is the Better Value Stock Right Now?
01:05pm, Monday, 24'th Jul 2023
Investors looking for stocks in the Medical - Biomedical and Genetics sector might want to consider either GSK (GSK) or Techne (TECH). But which of these two stocks is more attractive to value investo
GSK's HIV prevention drug gets European marketing nod
02:22am, Monday, 24'th Jul 2023
GSK Plc said on Monday that its HIV-focused unit ViiV Healthcare's cabotegravir injected drug and tablets got marketing authorisation from the European Medicines Agency.
The 3 Most Undervalued Pharma Stocks to Buy Now: July 2023
03:31pm, Friday, 21'st Jul 2023
Pharma stocks experienced an abysmal first half due to various factors. Rotation from defensive to cyclical sectors, drug price negotiations and upcoming patent cliffs have muddied the outlook.
GSK trading near year lows in run-up to results, questions remain for Dame Emma
02:37pm, Friday, 21'st Jul 2023
GSK PLC (LSE:GSK, NYSE:GSK) shares have been trading near year's lows earlier this month, despite a run of fairly good news in the run-up to its quarterly update on Wednesday. After hitting a decade
GSK Gears Up for Q2 Earnings: Will It Surpass Estimates?
02:28pm, Friday, 21'st Jul 2023
We expect GSK's specialty products like Cabenuva, Dovato, Bexsero, Breo Ellipta and Shingrix to drive second-quarter sales performance.
Are Medical Stocks Lagging GSK PLC Sponsored ADR (GSK) This Year?
11:27am, Thursday, 20'th Jul 2023
Here is how GSK (GSK) and Patterson Cos. (PDCO) have performed compared to their sector so far this year.
